4.3 Article

Chromosomal Instability as a Driver of Tumor Heterogeneity and Evolution

Journal

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a029611

Keywords

-

Funding

  1. Burroughs Wellcome Fund Career Award for Medical Scientists
  2. Stand Up to Cancer Innovative Research Grant
  3. Kimmel Scholar's Award
  4. ASH Scholar Award, Leukemia Lymphoma Society translational research program
  5. National Institutes of Health (NIH) [BD2K, 1K01ES025431-01]
  6. Department of Defense Breast Cancer Research Breakthrough Award [W81XWH-16-1-0315]
  7. Elsa U. Pardee Foundation
  8. NCI MSKCC Cancer Center Core Grant [P30 CA008748]

Ask authors/readers for more resources

Large-scale, massively parallel sequencing of human cancer samples has revealed tremendous genetic heterogeneity within individual tumors. Indeed, tumors are composed of an admixture of diverse subpopulations-subclones-that vary in space and time. Here, we discuss a principal driver of clonal diversification in cancer known as chromosomal instability (CIN), which complements other modes of genetic diversification creating the multilayered genomic instability often seen in human cancer. Cancer cells have evolved to fine-tune chromosome missegregation rates to balance the acquisition of heterogeneity while preserving favorable genotypes, a dependence that can be exploited for a therapeutic benefit. We discuss how whole-genome doubling events accelerate clonal evolution in a subset of tumors by providing a viable path toward favorable near-triploid karyotypes and present evidence for CIN-induced clonal speciation that can overcome the dependence on truncal initiating events.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available